Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Thiamet G has been used as an O-GlcNAcase inhibitor:to treat human embryonic kidney 293 cells in order to study its effect on Wnt/beta-catenin signallingto treat lytically-replicating producerto incubate mice (C57BL/6) aortic segments to increase global O-GlcNAc levels
Biochem/physiol Actions
Thiamet G is a potent inhibitor of the enzyme O-GlcNAcase (Ki = 21 nM). The compound is orally bioavailable and crosses the blood brain barrier. Thiamet G leads to an increase in O-GlcNAc-modified proteins in cell-based and in vivo assay systems, and reduces levels of phosphorylated Tau protein in rat cortex and hippocampus.
Packaging
5, 25 mg in glass bottle
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :